Liquidia Technologies, Inc. (NASDAQ:LQDA) Receives Consensus Rating of “Buy” from Analysts

Liquidia Technologies, Inc. (NASDAQ:LQDA) has been given a consensus recommendation of “Buy” by the ten research firms that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, seven have given a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $32.1111.

Several equities analysts have issued reports on LQDA shares. Oppenheimer set a $13.00 price target on Liquidia Technologies and gave the company an “underperform” rating in a research note on Monday, May 19th. Raymond James Financial upped their target price on Liquidia Technologies from $33.00 to $41.00 and gave the stock a “strong-buy” rating in a research report on Wednesday, August 13th. Wall Street Zen raised Liquidia Technologies from a “sell” rating to a “hold” rating in a research report on Thursday, May 22nd. BTIG Research reaffirmed a “buy” rating on shares of Liquidia Technologies in a research report on Tuesday, May 27th. Finally, HC Wainwright upped their target price on Liquidia Technologies from $29.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, May 28th.

Insider Activity at Liquidia Technologies

In other news, CEO Roger Jeffs sold 20,252 shares of the company’s stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $14.28, for a total transaction of $289,198.56. Following the transaction, the chief executive officer directly owned 1,038,560 shares of the company’s stock, valued at $14,830,636.80. This represents a 1.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Scott Moomaw sold 4,797 shares of the company’s stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $14.28, for a total value of $68,501.16. Following the transaction, the insider directly owned 223,231 shares in the company, valued at $3,187,738.68. The trade was a 2.10% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 90,277 shares of company stock valued at $1,469,392 over the last three months. 26.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Liquidia Technologies

Large investors have recently bought and sold shares of the stock. NewEdge Advisors LLC bought a new position in Liquidia Technologies during the 2nd quarter valued at $25,000. Hurley Capital LLC bought a new position in Liquidia Technologies during the 1st quarter valued at $32,000. GAMMA Investing LLC lifted its stake in Liquidia Technologies by 65.6% during the 1st quarter. GAMMA Investing LLC now owns 2,961 shares of the company’s stock valued at $44,000 after acquiring an additional 1,173 shares in the last quarter. Steward Partners Investment Advisory LLC lifted its stake in Liquidia Technologies by 24.0% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company’s stock valued at $77,000 after acquiring an additional 1,200 shares in the last quarter. Finally, Quarry LP bought a new position in Liquidia Technologies during the 1st quarter valued at $79,000. 64.54% of the stock is currently owned by institutional investors.

Liquidia Technologies Price Performance

Shares of LQDA opened at $26.84 on Friday. Liquidia Technologies has a 52-week low of $8.75 and a 52-week high of $28.00. The company has a debt-to-equity ratio of 9.84, a quick ratio of 2.41 and a current ratio of 2.49. The business’s 50 day moving average price is $17.51 and its two-hundred day moving average price is $15.96. The firm has a market cap of $2.31 billion, a PE ratio of -15.79 and a beta of 0.14.

Liquidia Technologies (NASDAQ:LQDA) last issued its quarterly earnings results on Tuesday, August 12th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.43) by ($0.06). Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The business had revenue of $8.84 million during the quarter, compared to analyst estimates of $3.90 million. Liquidia Technologies’s revenue was up 141.5% compared to the same quarter last year. On average, equities analysts anticipate that Liquidia Technologies will post -1.51 EPS for the current year.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).